Natalie Haddad, Pharm.D. (@NatalieHaddadRx) explains the mechanism of action of midodrine, reviews the current evidence for midodrine and its impact on vasopressor discontinuation and identifies midodrine’s role in therapy for vasopressor discontinuation.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.